Diabetes Mellitus (DM)
The metabolic and physiological consequences of diabetes mellitus regularly involve the kidney and lead to renal dysfunction. Although diabetes almost inevitably affects all elements of the kidney simultaneously, any given patient may present with features typically associated with one of the clinical patterns discussed above. Therefore, renal disease in some patients will present as an interstitial process, typically with hypertension and Type IV RTA. Others will have glomerular proteinuria as the initial clinical manifestation of the diabetic renal lesion. In either group, urinary tract infections and pyelonephritis frequently complicate the course of the diabetes.
Diabetic glomerulosclerosis is one of the more significant of the diabetic renal lesions and is the most frequent cause of end-stage renal failure in these patients. Glomerular disease occurs in about half of persons with juvenile-onset, insulin-dependent (Type I] diabetes mellitus. The onset of clinically apparent glomerular involvement oc- s curs, in most patients, between 15 and 20 years after the initial diagnosis of DM. Renal disease in DM is first seen as asymptomatic, episodic proteinuria, but progression to fixed, moderate to heavy proteinuria occurs rapidly, within one to two years. Glomerulopathy develops uncommonly in Type I diabetics who are free of proteinuria 20 years after diagnosis of DM.
Once proteinuria becomes established, a rapid fall in GFR follows, with the course to end-stage renal failure being complete within five years. Although the incidence of the nephrotic syndrome is low in DM, the prevalence of Type I DM in the population makes diabetic glomerulopathy a significant cause of adult nephrotic syndrome. The appearance of hypertension usually parallels that of proteinuria. Diabetic retinopathy is an invariant finding in patients with diabetic glomerulopathy and has led to the designation of the reti-norenal syndrome for persons so affected. The onset of the nephrotic syndrome in an individual having Type I DM for less than 10 years, or in the absence of diabetic retinopathy, should alert one to consider a nondiabetic etiology of the renal disease.
The classic glomerular lesion in DM is Kim-melstiel-Wilson nodular glomerulosclerosis. This appears as hyalin nodules lying in the center of peripheral capillary loops, causing the capillaries to lie in a ring surrounding the nodule. This pattern is actually seen in less than 25 per cent of cases of diabetic glomerulopathy. The more typical finding, seen most often when heavy proteinuria is present, is that of diffuse glomerulosclerosis associated with arteriosclerosis of both afferent and efferent arterioles. Basement membrane thickening and interstitial atrophy may be prominent. Immunofluorescent staining may show linear IgG and/or C3 deposition along capillaries, but this is thought to represent nonspecific trapping. Electron microscopy reveals diffuse increases in mesangial matrix material and generalized thickening of basement membranes by BM-like material.
Renal insufficiency is the major limit to survival in diabetics under 40 years of age. Treatment of end-stage renal disease in diabetics is more difficult than in nondiabetic patients, and the survival of diabetics on hemodialysis is less than that for nondiabetics. Continuous ambulatory peritoneal dialysis (CAPD) offers a better prognosis for many diabetics with renal failure. Death from cardiovascular complications is highly likely for the diabetic on dialysis. The most promising treatment for diabetic renal failure appears to be renal transplantation from a living, related donor. The diabetic lesion does recur in transplanted kidneys but has not been a significant cause of transplant kidney failure.
A significant number of diabetics display a prominent and characteristic interstitial lesion that appears related to ischemic injury. The syndrome of hyporeninemic hypoaldosteronism is a feature of this lesion and is a major cause of Type IV renal tubular acidosis. These patients will typically present with hyperkalemia and hyperchlo-remic metabolic acidosis with only a modest reduction in GFR. Hypertension is prominent in this syndrome. The clinical features of the interstitial lesion almost inevitably merge into the glomerular syndrome of diabetic glomerulosclerosis as the patient approaches end-stage renal failure.
Two other renal conditions frequently complicate the course of diabetic nephropathy. Papillary necrosis, especially in conjunction with renal infection, is common in diabetics. The sloughing of papillary tissue may cause acute ureteral obstruction with colic, may be associated with hematuria and passage of tissue in the urine, and may be identified by the calyceal irregularity seen on IVP. Although bacteriuria is no more prevalent in diabetics than nondiabetics, the syndrome of acute pyelonephritis, especially in the presence of urinary obstruction with papillary tissue, is a more frequent outcome of untreated bacteriuria in the diabetic.
- Management
- Visceral Angiography
- EFFECTORS OF THE RESPIRATORY SYSTEM
- Minimal Change Nephropathy
- PERICARDIAL EFFUSIOH
- LIMITATION OF MFARCT SIZE
- Metabolism of Drugs in Patients with Renal Insufficiency
- ADAPTATION TO NEPHRON LOSS
- SPECIFIC MANIFESTATIONS OF RENAL DISEASE
- Renal Biopsy and Other Diagnostic Tests
- GRANULOMATOUS LIVER DISEASE
- Hepatic Diseases
- APPROACH TO THE PATIENT WITH SUSPECTED OR CONFIRMED ARRHYTHMIAS
- Resuscitation
- Hepatic Encephalopathy
- Community Acquired Pneumonia
- VARIATiT ANGINA
- SCREENING TESTS OF HEPATOBILIARY DISEASE
- RISK FACTORS
- EMPHYSEMA
- PATHOPHYSIOLOGY OF AIRWAY OBSTRUCTION
- VENTILATION
- GAS TRANSFER
- CLINICAL AMD LABORATORY FEATURES
- CLINICAL MANIFESTATIONS OF ENDSTAGE RENAL DISEASE
- CARDIOVASCULAR PHYSIOLOGY DURING PREGNANCY - ELECTROPHYSIOLOGY
- MEDIASTINAL DISEASE
- HEART DISEASE AND PREGNANCY
- TREATMENT
- Ovarian Cancer
- Outcome and Prognosis
- OBSTRUCTIVE LUNG DISEASE
- RENAL PHARMACOLOGY
- OXYGEN
- Conjugated Hyperbilirubinemia